Top first-in-class drug candidates of 2025: Ionis’ donidalorsen, Sanofi’s fitusiran, Cytokinetics’ aficamten await FDA approval

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Fluticasone Propionate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 29 USDMF, 30 CEP/COS, 6 JDMF, 7 EU WC, 2 KDMF, 27 NDC API, 44 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

428 FDF Dossiers, 70 FDA Orange Book, 212 Europe, 32 Canada, 22 Australia, 41 South Africa, 51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SPRAY, METERED;NASAL - 0.05MG/SPRAY, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.25MG/INH, POWDER;INHALATION - 0.03MG/INH, POWDER;INHALATION - 0.055MG/INH, POWDER;INHALATION - 0.113MG/INH, POWDER;INHALATION - 0.232MG/INH, POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.044MG/INH, AEROSOL, METERED;INHALATION - 0.11MG/INH, AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 2 SPI Pharma, 2 DKSH, 2 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 10 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 5 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 20 Kerry, 1 Kima Chemical, 10 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 10 Roquette, 8 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 21 Solubilizers, 20 Thickeners and Stabilizers, 19 Topical, 16 Direct Compression, 14 Disintegrants & Superdisintegrants, 13 Parenteral, 12 Granulation, 10 Co-Processed Excipients, 10 Emulsifying Agents, 9 Controlled & Modified Release, 7 Film Formers & Plasticizers, 7 Rheology Modifiers, 6 Coating Systems & Additives, 6 Surfactant & Foaming Agents, 3 Taste Masking, 2 Chewable & Orodispersible Aids, 1 Lubricants & Glidants, 1 API Stability Enhancers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 142 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 164 Regulatory FDF Prices, 12 Annual Reports

MARKET PLACE

16 APIs, 4 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

551 US Patents, 11 US Exclusivities, 53 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 7 USP, 9 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
30/12/2024	EUROAPI	France	EUROAPI FRANCE	303MF10172	Fluticasone propionate	2021-12-09	2021-12-09	15 rue Traversie(')re 75012 Paris France
30/12/2024	Seqens	France	Wavelength Enterprises Ltd	218MF10834	Fluticasone propionate	2006-10-20	2021-05-13	Offer Park, Building C, 4th floor, 94 Shlomo Shmeltzer Road, POB 3158, Petah Tikva 4970602, Israel

Fluticasone Propionate

Fluticasone Propionate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

68 API Suppliers

29 USDMF

30 CEP/COS

6 JDMF

7 EU WC

2 KDMF

27 NDC API

44 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

50 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

428 FDF Dossiers

70 FDA Orange Book

212 Europe

32 Canada

22 Australia

41 South Africa

51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY

SPRAY, METERED;NASAL - 0.05MG/SPRAY

POWDER;INHALATION - 0.05MG/INH

POWDER;INHALATION - 0.1MG/INH

POWDER;INHALATION - 0.25MG/INH

POWDER;INHALATION - 0.03MG/INH

POWDER;INHALATION - 0.055MG/INH

POWDER;INHALATION - 0.113MG/INH

POWDER;INHALATION - 0.232MG/INH

POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH

POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH

POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH

LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.044MG/INH

AEROSOL, METERED;INHALATION - 0.11MG/INH

AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Rochem International Inc

2 SPI Pharma

2 DKSH

2 Faran Shimi Pharmaceutical

4 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

10 Actylis

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 BASF

5 DFE Pharma

2 Finar

7 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

20 Kerry

1 Kima Chemical

10 Microlex e.U

1 Nanjing Bold Chemical

1 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

10 Roquette

8 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

OINTMENT;TOPICAL - 0.005% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.05MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons